New User? Click here to register

New treatments and perspectives in metastatic TNBC with PARP Inhibitors.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Benjamin VERRET
Oncologist, Villejuif, France

De-escalation in HER2+ Tumors: What Can Imaging Tell Us?
Paula Borralho
What are the update of DESTINY BREAST 12 in HER2 positive disease with brain metastatis ?
Hassan GHAZAL
oncologist, Dubai
Updates from National Health Organizations
Isabelle THOMASSIN-NAGGARA
Can you present the challenges of the AROME session?
Yazid BELKACEMI
Oncologist-Radiotherapist, Créteil, France
Tailoring Neoadjuvant Therapy: Imaging as a Predictive Tool.
Joana Loureiro